Home › NDC Lookup › RxCUI directory › RxCUI 2712652

10 ML penpulimab-kcqx 10 MG/ML Injection — RxCUI 2712652

RxNorm drug concept · Semantic clinical drug
RxCUI 2712652 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2712652
Official name10 ML penpulimab-kcqx 10 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspenpulimab-kcqx 100 MG per 10 ML Injection; penpulimab-kcqx 100 MG in 10 ML Injection
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Penpulimab: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Penpulimab is a type of cancer treatment called an immunotherapy — specifically, a PD-1 blocking antibody. Instead of directly killing cancer cells like chemotherapy does, it works...
  • What exactly is Penpulimab and why has my doctor prescribed it?
  • Penpulimab is given as an IV infusion at a clinic or infusion center — it goes directly into your vein over 60 minutes. If you're receiving it with chemotherapy, you'll come in eve...
  • How is Penpulimab given, and how often will I need to come in?
📖 Read our full Penpulimab guide →

🕸️ Concept Web — How 10 ML penpulimab-kcqx 10 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 10 ML penpulimab-kcqx 10 MG/ML Injection RxCUI 2712652

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Penpulimab 2712542
    • Penpulimab-kcqx 2712646
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Penpulimab Injection 2712649
    • Penpulimab-kcqx Injection 2712651
    • Penpulimab Injectable Product 2712648
    • Penpulimab-kcqx Injectable Product 2712650
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Penpulimab-kcqx 10 MG/ML 2712647

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Penpulimab-kcqx 10 MG/ML SCDC · 2712647
  • Penpulimab Injection SCDF · 2712649
  • Penpulimab-kcqx Injection SCDFP · 2712651
  • Penpulimab Injectable Product SCDG · 2712648
  • Penpulimab-kcqx Injectable Product SCDGP · 2712650

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2712652 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
83654-0105-01 1 VIAL, SINGLE-DOSE in 1 BOX (83654-105-01) / 10 mL in 1 VI... Penpulimab kcqx Akeso Biopharma, Co., Ltd 2025-04-23
Observed labelers: Akeso Biopharma, Co., Ltd (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.